Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001829126-25-008289
Filing Date
2025-10-20
Accepted
2025-10-20 21:40:20
Documents
1
Period of Report
2025-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 ownership.html 4  
1 FORM 4 ownership.xml 4 8625
  Complete submission text file 0001829126-25-008289.txt   10080
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O R01 CAPITAL LLC 1111 LINCOLN AVENUE, SUITE 500 MIAMI BEACH FL 33139
Business Address
Kazley Michael John (Reporting) CIK: 0002091727 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 251405256